Notice for lurbinectedin (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
lurbinectedin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
IV injection/powder for solution;
Indication
For the treatment of small cell lung cancer
Therapeutic area
Respiratory